A predictive index of axillary nodal involvement in operable breast cancer

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1241-1247

  De Laurentiis, M ^a,b   Gallo, C ^b,c   De Placido, S ^a,b   Perrone, F ^a,b   Pettinato, G ^a   Petrella, G ^a   Carlomagno, C ^a,b   Panico, L ^c   Delrio, P ^a   Bianco, A R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Axillary lymph node dissection; Axillary nodal metastases; Breast cancer; Multivariate analysis; Predictive index; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BLOOD VESSEL; BREAST CANCER; CANCER CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NIPPLE; PREDICTION; PRIORITY JOURNAL;

EID: 9344259156     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.238     Document Type: Article

References (59)

1. AHLGREN J, STAL O, WESTMAN G AND ARNESSON L. (1994). Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncologica, 33, 603-608.
2. ALAM SM, WHITFORD P, CUSHLEY W, GEORGE WD AND CAMPBELL AM. (1990). Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br. J. Cancer, 62, 238-242.
3. ALDRICH JH AND NELSON FD. (1984). Linear probability logit and probit models. pp. 7-45. Sage pubns: Beverly Hills and London.
4. AXELSSON CK, MOURIDSEN HT AND ZEDELER K. (1992). Axillary dissection of level i and ii lymph nodes is important in breast cancer classification. Eur. J. Cancer, 28A, 1415-1418.
5. AZZOPARDI JG, CHEPICK OF, HARTMANN WH, JAFAREY NA, LLOMBART-BOSCH A, OZZELLO L, RILKE F, SASANO N, SOBIN LH, SOMMERS SC, STALSBERG H, SUGAR J AND WILLIAMS AO. (1982). The World Health Organization histological typing of breast tumors second edition. Am. J. Clin. Pathol., 78, 806-816.
6. BERGER MS, LOCHER GW, SAURER S, GULLICK WJ, WATERFIELD MD, GRONER B AND HYNES NE. (1988). Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res., 48, 1238-1243.
7. BLOOM HJG AND RICHARDSON WW. (1957). Histological grading and prognosis in breast cancer: a study of 1409 cases of which 539 have been followed for 15 years. Br. J. Cancer. 11, 359-377.
8. BORG A, BALDETORP B, FERNO M, KILLANDER D, OLSSON H AND SIGURDSSON H. (1991). ErbB-2 amplification in breast cancer with a high rate of proliferation. Oncogene, 6, 137-143.
9. BOSARI S, LEE AK, DELELLIS RA, WILEY BD, HEATLEY GJ AND SILVERMAN ML. (1992). Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23, 755-761.
10. BOUROCHE JM AND SAPORTA G. (1980). L'analyse des donnqes. PUF: Paris.
11. BROOKS SA AND LEATHEM AJ. (1991). Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet, 338, 71-74.
12. CABANES PA, SALMON RJ, VILCOQ JR, DURAND JC, FOURQUET A, GAUTIER C AND ASSELAIN B. (1992). Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet, 339, 1245-1248.
13. CADY B. (1995). The need to reexamine axillary lymph node dissection in invasive breast cancer (editorial). Cancer, 73, 505-508.
14. CANCER RESEARCH CAMPAIGN WORKING PARTY. (1980). Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: a detailed update at the tenth year. Lancet, 55-60.
15. CHADHA M, CHABON AB, FRIEDMANN P AND VIKRAM B. (1994). Predictors of axillary lymph node metastases in patients with t1 breast cancer: a multivariate analysis. Cancer, 73, 350-353.
16. CLARK GM, HILSENBECK SG, RAVDIN PM, DE LAURENTIIS M AND OSBORNE CK. (1994). Prognostic factors: Rationale and methods of analysis and integration. Breast Cancer Res. Treat., 32, 105-112.
17. COX DR AND SNELL EJ. (1989). Analysis of binary data. Chapman and Hall: London.
18. DE LAURENTIIS M AND RAVDIN PM. (1994a). A technique for using neural network analysis to perform survival analysis of censored data. Cancer Lett., 17, 127-138.
19. DE LAURENTIIS M AND RAVDIN PM. (1994b). Survival analysis of censored data: neural network detection of complex interaction between variables. Breast Cancer Res. Treat., 32, 113-118.
20. DE LAURENTIIS M, DE PLACIDO S, GALLO C, PERRONE F, CARLOMAGNO C, BIANCO AR, CLARK GM AND RAVDIN PM. (1994). A predictive model of axillary lymph node involvement in breast cancer patients. Ann. Oncol., 5, 15.
21. DECKERS P. (1991). Axillary dissection in breast cancer: when, why, how much, and for how long? Another operation soon to be extinct? J. Surg. Oncol., 48, 217-219.
22. FENTIMAN IS. (1993). Axillary surgery in breast cancer: what debate? Eur. J. Cancer, 29A, 923.
23. FENTIMAN IS AND CHETTY U. (1992). Axillary surgery in breast cancer - is there still a debate? Eur. J. Cancer, 28A, 1013-1014.
24. FENTIMAN IS AND MANSEL RE. (1991). The axilla: not a no-go zone. Lancet, 337, 221-223.
25. FENTIMAN IS, HAYWARD JL, RODGER A, SACKS NPM, BAUM M, BARR LC, OZA AM, RAWLINGS G, TANNOCK IF, WHITAKER SJ, WILSON CBJH, HUDDART RA, YARNOLD JR, CABANES PA, SALMON RJ, AKTAN AO, YEGEN C, YALIN R AND BOZKURT S. (1992). Axillary node dissection in breast cancer. Lancet, 340, 245-246.
26. FISHER B. (1992). The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res., 52, 2371-2383.
27. FISHER B, REDMOND C, FISHER ER, BAUER M, WOLMARK N, WICKERHAM DL, DEUTSCH M, MONTAGUE E AND MARGOLESE RAI R. (1985). Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N. Engl. J. Med., 312, 674-681.
28. GREENACRE M. (1992). Correspondence analysis in medical research. Stat. Methods Med. Res., 1, 97-117.
29. HENNESSY C, HENRY JA, MAY FE, WESTLEY BR, ANGUS B AND LENNARD TW. (1991). Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl Cancer Inst., 83, 281-285.
30. HLADIUK M, HUCHCROFT S, TEMPLE W AND SCHNURR BE. (1992). Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J. Surg. Oncol., 50, 47-52.
31. HORAK ER, LEEK R, KLENK N, LEJEUNE S, SMITH K, STUART N, GREENALL M, STEPNIEWSKA K AND HARRIS AL. (1992). Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340, 1120-1124.
32. KAPLAN EL AND MEIER P. (1958). Non parametric estimation from incomplete observation. J. Am. Stat. Assoc., 53, 457-481.
33. KIRICUTA CI AND TAUSCH J. (1992). A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer, 69, 2496-2501.
34. KISSIN MW, QUERCI DELLA ROVERE G, EASTON G AND WESTBURY G. (1986). Risk of lymphedema following the treatment of breast cancer. Br. J. Surg., 73, 580-585.
35. LEMESHOW S AND HOSMER DW JR. (1982). A review of goodness of fit statistics for use in the development of logistic regression models. Am. J. Epidemiol., 115, 92-106.
36. LIN PP, ALLISON DC, WAINSTOCK J, MILLER KD, DOOLEY WC, FRIEDMAN N AND BAKER RR. (1993). Impact of axillary lymph node dissection on the therapy of breast cancer patients. J. Clin. Oncol., 11, 1536-1544.
37. MANTEL N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem. Rep., 50, 163-170.
38. MARGOLESE RG. (1993). Axillary surgery in breast cancer - there still is a debate. Eur. J. Cancer, 29A, 801.
39. MATHIENSEN O, CARL J, BONDERUP O AND PANDURO J. (1990). Axillary sampling and the risk of erroneous staging of breast cancer. Acta Oncol., 29, 721-725.
40. MAZERON JJ, OTMEZGUINE Y, HUART J AND PIERQUIN B. (1985). Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients. Lancet, 2, 1387.
41. MENARD S, BUFALINO R, RILKE F, CASCINELLI N, VERONESI U AND COLNAGHI MI. (1994). Prognosis based on primary breast carcinoma instead of pathological nodal status. Br. J. Cancer, 70, 709-712.
42. RAVDIN PM AND CLARK GM. (1992). A practical application of neural network analysis for predicting outcome of individual breast cancer patients. Breast Cancer Res. Treat., 22, 285-293.
43. RAVDIN PM, CLARK GM, HILSENBECK SG, OWENS MA, VENDELY P, PANDIAN MR AND MCGUIRE WL. (1992). A demonstration that breast cancer recurrence can be predicted by neural network analysis. Breast Cancer Res. Treat., 21, 47-53.
44. RAVDIN PM, CLARK GM, HOUGH JJ, OWENS MA AND MCGUIRE WL. (1993). Neural network analysis of DNA flow cytometry histograms. Cytometry, 14, 74-80.
45. RADVIN PM, DE LAURENTIIS M, VENDELY T AND CLARK GM. (1994). Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J. Natl Cancer Inst., 86, 1771-1775.
46. ROBINSON DS, SENOFSKY GM AND KETCHAM AS. (1992). Role and extent of lymphadenectomy for early breast cancer. Semin. Surg. Oncol., 8, 78-82.
47. ROSE CM, BOTNICK LE, WEINSTEIN M, HARRIS JR, KOUFMAN C, SILEN W AND HELLMAN S. (1983). Axillary sampling in the definitive treatment of breast cancer by radiation therapy and lumpectomy. Int. J. Radiat. Oncol. Biol. Phys., 9, 339-344.
48. ROYDS JA, STEPHENSON TJ, REES RC, SHORTHOUSE AJ AND SILCOCKS PB. (1993). Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J. Natl Cancer Inst., 85, 727-731.
49. RUMELHART DE, HINTON GE AND WILLIAMS RJ. (1986). Learning representation by back propagating errors. Nature, 323, 533-536.
50. SHEK LLM AND GODOLPHIN W. (1988). Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration and tumor necrosis. Cancer Res., 48, 5565-5569.
51. TABAR L, FAGERBERG CJG AND GAD A. (1985). Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet, 1, 829-832.
52. TABAR L, FAGERBERG G, DAY N, DUFFY S AND KITCHIN R. (1992). Breast cancer treatment and natural history: new insights from results of screening. Lancet, 339, 412-414.
53. TJANDRA JJ, RUSSEL IS, COLLINS JP, ANDREW JT, LICHTENSTEIN M, BINNS D AND MCKENZIE IF. (1989). Immuno lymphoscintigraphy for the detection of lymph node metastases from breast cancer. Cancer Res., 49, 1600-1608.
54. TODD JH, DOWLE C, WILLIAMS M, ELSTON CW, ELLIS IO, HINTON CP, BLAMEY RW AND HAYBITTLE JL. (1987). Confirmation of a prognostic index in primary breast cancer. Br. J. Cancer, 56, 489-492.
55. TOMA S, LEONESSA F, ROMANINI A, BADELLINO F, BONASSI S, NICOLO G AND ROSSO R. (1991). Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer. Anticancer Res., 11, 1439-1444.
56. VAN DONGEN JA. (1987). Subclavicular biopsy as a guideline for the treatment of breast cancer. World J. Surg., 1, 306-308.
57. WEIDNER N, SEMPLE JP, WELCH WR AND FOLKMAN J. (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324, 1-8.
58. WEIDNER N, FOLKMAN J, POZZA F, BEVILACQUA P, ALLRED EN, MOORE DH, MELI S AND GASPARINI G. (1992). Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl Cancer Inst., 84, 1875-1887.
59. WHITE H. (1989). Learning in artificial neural networks: a statistical approach. Neural Comp., 1, 425-464.